Advance could expand immune therapy as a cancer treatment | Chemistry The development of antibody-lectin chimeras, which started in the lab of Stanford chemist Carolyn Bartozzi, shows promise in blocking the defenses put up by cancer cells and allowing the immune system...

Stanford’s Carolyn Bertozzi is leading a new cancer immunotherapy approach that helps the immune system see tumors by disrupting sugar-based camouflage - expanding who may benefit from treatment.

Learn more: chemistry.stanford.edu/news/advance...

#ImmunoOncology #BioorthogonalChemistry

2022 Nobel Prize winner in Chemistry, #Stanford Prof. Carolyn Bertozzi, delivered an inspiring lecture on #BioorthogonalChemistry at #PekingUniversity on Aug. 28.

@stanford.edu @carolynbertozzi.bskyverified.social

You'd be right in thinking that all this sounds like #BioorthogonalChemistry, however there is a key distinction to be made.

The orthogonal part of bioorthogonal chemistry means that the chemical reaction occurs in the presence of living cells, but not directly interface with cellular metabolism

#research #triazines #clickreaction #bioorthogonalchemistry
Bioorthogonal Cycloadditions of C3-Trifluoromethylated 1,2,4-Triazines with trans-Cyclooctenes (Vrabel): doi.org/10.1002/chem...